Pfizer Inc. et al v. Aurobindo Pharma Limited et al
| Pfizer Inc. and Pfizer Ireland Pharmaceuticals |
| Apitoria Pharma Private Limited, Aurobindo Pharma U.S.A., Inc. and Aurobindo Pharma Limited |
| 1:2024cv00622 |
| May 23, 2024 |
| U.S. District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 8, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 13
ORDER: on or before August 9, 2024, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/ or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER Setting Deadlines: ( Notice of Compliance deadline set for 8/9/2024.) Signed by Judge Colm F. Connolly on 7/8/2024. Associated Cases: 1:24-cv-00621-CFC et al.(nmf)
|
| Pro Hac Vice Attorney Joel L. Broussard for Pfizer Inc. and for Pfizer Ireland Pharmaceuticals added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
| Pro Hac Vice Attorney Dimitrios T. Drivas for Pfizer Inc. and for Pfizer Ireland Pharmaceuticals added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
| Pro Hac Vice Attorney John P. Scheibeler for Pfizer Inc., and Pfizer Ireland Pharmaceuticals added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
| Filing 12 Pro Hac Vice Fee - Credit Card Payment received for Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard. ( re #11 MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard )( Payment of $ 150, receipt number ADEDC-4419012).(Dellinger, Megan) |
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard - filed by Pfizer Inc., Pfizer Ireland Pharmaceuticals, Bristol-Myers Squibb Company, Pfizer Ireland Pharmaceutials. (Dellinger, Megan) |
|
SO ORDERED, re (8 in 1:24-cv-00626-CFC, 8 in 1:24-cv-00627-CFC, 10 in 1:24-cv-00625-CFC, 11 in 1:24-cv-00622-CFC, 9 in 1:24-cv-00623-CFC, 10 in 1:24-cv-00624-CFC, 9 in 1:24-cv-00621-CFC) MOTION for Pro Hac Vice Appearance of Attorneys Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard, filed by Pfizer Inc., Pfizer Ireland Pharmaceutials, Bristol-Myers Squibb Company, Pfizer Ireland Pharmaceuticals. Ordered by Judge Colm F. Connolly on 5/30/2024. Associated Cases: 1:24-cv-00621-CFC et al.(kmd)
|
| Filing 10 STANDING ORDER REGARDING BRIEFING IN ALL CASES Associated Cases: 1:24-cv-00621-CFC et al.(nmf) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:24-cv-00621-CFC through 1:24-cv-00627-CFC (rjb) |
| Filing 9 WAIVER OF SERVICE returned executed by Pfizer Ireland Pharmaceuticals, Pfizer Inc.: For Aurobindo Pharma U.S.A., Inc. waiver sent on 5/24/2024, answer due 7/23/2024. (Dellinger, Megan) |
| Filing 8 WAIVER OF SERVICE returned executed by Pfizer Ireland Pharmaceuticals, Pfizer Inc.: For Aurobindo Pharma Limited waiver sent on 5/24/2024, answer due 7/23/2024. (Dellinger, Megan) |
| Filing 7 WAIVER OF SERVICE returned executed by Pfizer Ireland Pharmaceuticals, Pfizer Inc.: For Apitoria Pharma Private Limited waiver sent on 5/24/2024, answer due 7/23/2024. (Dellinger, Megan) |
| Filing 6 Summons Issued as to Apitoria Pharma Private Limited on 5/23/2024; Aurobindo Pharma Limited on 5/23/2024; Aurobindo Pharma U.S.A., Inc. on 5/23/2024. (Attachments: #1 Summons Issued, #2 Summons Issued)(oam) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Pfizer Inc. for Pfizer Ireland Pharmaceuticals filed by Pfizer Inc., Pfizer Ireland Pharmaceuticals. (oam) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,083,724 B2. (oam) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: April 18, 2024. Date of Expiration of Patent: March 25, 2039.Thirty Month Stay Deadline: 8/27/2027. (oam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) |
| Filing 1 COMPLAINT filed for PATENT INFRINGEMENT against Apitoria Pharma Private Limited, Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc. ( Filing fee $ 405, receipt number ADEDC-4414647.) - filed by Pfizer Ireland Pharmaceuticals, Pfizer Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(oam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
